PTC Therapeutics Inc (PTCT) — Capital Reinvestment Ratio
PTC Therapeutics Inc (PTCT) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow ($870.10 Million) in capital expenditures ($2.53 Million). See PTC Therapeutics Inc net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PTC Therapeutics Inc Capital Reinvestment Ratio (2025–2025)
This chart tracks PTC Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check PTCT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for PTC Therapeutics Inc (2025–2025)
Year-by-year Capital Reinvestment Ratio for PTC Therapeutics Inc from 2025 to 2025. For live market cap and broader valuation context, see PTCT market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $711.20 Million | $8.86 Million | — |